Kingsmead Medical Services Limited 13899760 false 2024-03-01 2025-02-28 2025-02-28 The principal activity of the company is that of consultancy services in relation to pharmaceuticals. Digita Accounts Production Advanced 6.30.9574.0 true 13899760 2024-03-01 2025-02-28 13899760 2025-02-28 13899760 bus:OrdinaryShareClass1 2025-02-28 13899760 bus:OrdinaryShareClass2 2025-02-28 13899760 bus:OrdinaryShareClass3 2025-02-28 13899760 core:RetainedEarningsAccumulatedLosses 2025-02-28 13899760 core:ShareCapital 2025-02-28 13899760 core:CurrentFinancialInstruments 2025-02-28 13899760 core:CurrentFinancialInstruments core:WithinOneYear 2025-02-28 13899760 core:FurnitureFittingsToolsEquipment 2025-02-28 13899760 bus:SmallEntities 2024-03-01 2025-02-28 13899760 bus:AuditExemptWithAccountantsReport 2024-03-01 2025-02-28 13899760 bus:FilletedAccounts 2024-03-01 2025-02-28 13899760 bus:SmallCompaniesRegimeForAccounts 2024-03-01 2025-02-28 13899760 bus:RegisteredOffice 2024-03-01 2025-02-28 13899760 bus:Director1 2024-03-01 2025-02-28 13899760 bus:Director2 2024-03-01 2025-02-28 13899760 bus:OrdinaryShareClass1 2024-03-01 2025-02-28 13899760 bus:OrdinaryShareClass2 2024-03-01 2025-02-28 13899760 bus:OrdinaryShareClass3 2024-03-01 2025-02-28 13899760 bus:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 13899760 bus:Agent1 2024-03-01 2025-02-28 13899760 core:FurnitureFittingsToolsEquipment 2024-03-01 2025-02-28 13899760 core:OfficeEquipment 2024-03-01 2025-02-28 13899760 countries:England 2024-03-01 2025-02-28 13899760 2024-02-29 13899760 core:FurnitureFittingsToolsEquipment 2024-02-29 13899760 2023-03-01 2024-02-29 13899760 2024-02-29 13899760 bus:OrdinaryShareClass1 2024-02-29 13899760 bus:OrdinaryShareClass2 2024-02-29 13899760 bus:OrdinaryShareClass3 2024-02-29 13899760 core:RetainedEarningsAccumulatedLosses 2024-02-29 13899760 core:ShareCapital 2024-02-29 13899760 core:CurrentFinancialInstruments 2024-02-29 13899760 core:CurrentFinancialInstruments core:WithinOneYear 2024-02-29 13899760 core:FurnitureFittingsToolsEquipment 2024-02-29 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 13899760

Kingsmead Medical Services Limited

Unaudited Filleted Financial Statements

for the Year Ended 28 February 2025

 

Kingsmead Medical Services Limited

Contents

Company Information

1

Accountants' Report

2

Balance Sheet

3 to 4

Notes to the Unaudited Financial Statements

5 to 9

 

Kingsmead Medical Services Limited

Company Information

Directors

Dr D A Hull

Dr P E Schmidt

Registered office

Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN

Accountants

MMO Limited
Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN

 

Chartered Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
Kingsmead Medical Services Limited
for the Year Ended 28 February 2025

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Kingsmead Medical Services Limited for the year ended 28 February 2025 as set out on pages 3 to 9 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at
http://www.icaew.com/regulation.

This report is made solely to the Board of Directors of Kingsmead Medical Services Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Kingsmead Medical Services Limited and state those matters that we have agreed to state to the Board of Directors of Kingsmead Medical Services Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Kingsmead Medical Services Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Kingsmead Medical Services Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Kingsmead Medical Services Limited. You consider that Kingsmead Medical Services Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Kingsmead Medical Services Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................

MMO Limited
Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN

22 September 2025

 

Kingsmead Medical Services Limited

(Registration number: 13899760)
Balance Sheet as at 28 February 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

4

3,696

3,532

Current assets

 

Debtors

5

15,373

30,087

Cash at bank and in hand

 

28,672

67,061

 

44,045

97,148

Creditors: Amounts falling due within one year

6

(43,802)

(64,702)

Net current assets

 

243

32,446

Total assets less current liabilities

 

3,939

35,978

Provisions for liabilities

(924)

(671)

Net assets

 

3,015

35,307

Capital and reserves

 

Called up share capital

7

120

120

Retained earnings

2,895

35,187

Shareholders' funds

 

3,015

35,307

For the financial year ending 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 10 September 2025 and signed on its behalf by:
 

 

Kingsmead Medical Services Limited

(Registration number: 13899760)
Balance Sheet as at 28 February 2025

.........................................
Dr D A Hull
Director

.........................................
Dr P E Schmidt
Director

 

Kingsmead Medical Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 28 February 2025

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN
England

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Kingsmead Medical Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 28 February 2025

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office equipment

25% - written down value

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

 

Kingsmead Medical Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 28 February 2025

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2024 - 2).

 

Kingsmead Medical Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 28 February 2025

4

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 March 2024

5,669

5,669

Additions

1,396

1,396

At 28 February 2025

7,065

7,065

Depreciation

At 1 March 2024

2,137

2,137

Charge for the year

1,232

1,232

At 28 February 2025

3,369

3,369

Carrying amount

At 28 February 2025

3,696

3,696

At 29 February 2024

3,532

3,532

5

Debtors

Current

2025
£

2024
£

Trade debtors

14,117

27,323

Prepayments

1,256

2,764

 

15,373

30,087

6

Creditors

Creditors: amounts falling due within one year

2025
£

2024
£

Due within one year

Taxation and social security

39,897

62,446

Accruals and deferred income

2,220

2,220

Other creditors

1,685

36

43,802

64,702

 

Kingsmead Medical Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 28 February 2025

7

Share capital

Allotted, called up and fully paid shares

2025

2024

No.

£

No.

£

Ordinary shares of £1 each

100

100

100

100

Ordinary A shares of £1 each

10

10

10

10

Ordinary B shares of £1 each

10

10

10

10

120

120

120

120